The anti-PLA2R antibody in circulation binds to PLA2R on the surface of podocytes to form an electron-dense deposit under the foot process and epithelium, thereby activating the complement-forming membrane attack complex, causing podocyte and kidney damage (Glassock, 2012). Here, PLA2R1 is linked to urogenital neoplasm.